Barclays’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2
| Closed | – | – | 5450 |
|
|
2024
Q1 | $0 | Buy |
+2
| New | +$1 | ﹤0.01% | 5501 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6763 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 7200 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 7609 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 7574 |
|
|
2017
Q2 | – | Hold |
0
| – | -$14K | – | 7168 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 5969 |
|
|
2016
Q4 | – | Hold |
0
| – | -$23K | – | 7017 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 5417 |
|
|
2015
Q4 | – | Hold |
0
| – | -$1K | – | 6971 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 6722 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 6236 |
|
Barclays's NVIV Position: Q2 2024 in Review
Barclays sold out of InVivo Therapeutics Holdings Corp (NVIV) in Q2 2024, closing a stake of 2 shares.
Barclays first reported a position in NVIV in Q1 2024 and held it in 1 quarter. The position peaked at $0 in Q1 2024. 0 funds tracked by Wall St. Rank hold NVIV as of Q2 2024.
- Barclays reported no remaining InVivo Therapeutics Holdings Corp position as of Q2 2024 after selling out during the quarter.
- Barclays sold 2 InVivo Therapeutics Holdings Corp shares in Q2 2024.
- Barclays first reported a position in InVivo Therapeutics Holdings Corp in Q1 2024 and held it in 1 quarter.
- Barclays's InVivo Therapeutics Holdings Corp position peaked at $0 in Q1 2024.
- 0 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q2 2024.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.